Atypical Clinical Presentations of Pediatric Acute Immune-Mediated Polyneuropathy

Naama Yosha-Orpaz1, Sharon Aharoni2,3, Malcolm Rabie2

  • 11 Pediatric Neurology Unit, Edith Wolfson Medical Center, Holon, Israel.

Insights

Guillain-Barré syndrome (GBS) in children can present with atypical symptoms and requires prompt recognition. While most children recover fully, some develop chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), impacting long-term outcomes.

Area of Science:

  • Pediatric Neurology
  • Neuromuscular Disorders
  • Clinical Electrophysiology

Background:

  • Guillain-Barré syndrome (GBS) is a leading cause of acute flaccid paralysis in children.
  • The acute phase can be severe, affecting respiratory and autonomic functions.
  • Despite potential severity, most children experience good prognoses and recovery.

Purpose of the Study:

  • To characterize clinical and electrophysiologic findings in pediatric GBS patients.
  • To identify atypical presentations and long-term outcomes in children with GBS.
  • To differentiate GBS from chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) in children.

Main Methods:

  • Retrospective review of 39 pediatric GBS cases from 2009-2015 at a tertiary center.
  • Data collection included clinical presentation, respiratory complications, and neurologic outcomes.
  • Electrophysiologic studies were analyzed for patients with GBS.

Main Results:

  • Atypical GBS presentations included asymmetric weakness (23%), nonascending weakness (30%), and normal reflexes (28%).
  • Eight children were diagnosed with CIDP; 71% of GBS patients recovered fully versus 14% with CIDP.
  • Neurologic sequelae were observed in 29% of GBS patients and 86% with CIDP.

Conclusions:

  • Clinicians must recognize atypical GBS symptoms in children.
  • Early diagnosis and differentiation from CIDP are crucial for appropriate management and predicting outcomes.
  • While GBS generally has a good prognosis, vigilance for atypical signs and potential CIDP is essential.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
559
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
828
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
365
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
269
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K